Guidelines for the management of pemphigus vulgaris

被引:161
|
作者
Harman, KE [1 ]
Albert, S [1 ]
Black, MM [1 ]
机构
[1] St Thomas Hosp, St Johns Inst Dermatol, London SE1 7EH, England
关键词
guidelines; immunosuppression; management; pemphigus vulgaris; therapy; treatment;
D O I
10.1111/j.1365-2133.2003.05665.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
These guidelines for management of pemphigus vulgaris have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.
引用
收藏
页码:926 / 937
页数:12
相关论文
共 50 条
  • [41] The immunogenetics of pemphigus vulgaris
    Gazit, E
    Loewenthal, R
    AUTOIMMUNITY REVIEWS, 2005, 4 (01) : 16 - 20
  • [42] Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus
    Ohata, Chika
    Ishii, Norito
    Furumura, Minao
    JOURNAL OF CUTANEOUS PATHOLOGY, 2014, 41 (11) : 880 - 889
  • [43] Contact pemphigus vulgaris?
    Stransky, L
    CONTACT DERMATITIS, 1998, 38 (01) : 45 - 45
  • [44] Pemphigus vulgaris on the palms
    Masala, MV
    Cozzani, E
    Rosella, M
    Montesu, MA
    EUROPEAN JOURNAL OF DERMATOLOGY, 1997, 7 (06) : 453 - 454
  • [45] Outcome of pemphigus vulgaris
    Kavusi, S.
    Daneshpazhooh, M.
    Farahani, F.
    Abedini, R.
    Lajevardi, V.
    Chams-Davatchi, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (05) : 580 - 584
  • [46] Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
    Joly, P.
    Horwath, B.
    Patsatsi, A.
    Uzun, S.
    Bech, R.
    Beissert, S.
    Bergman, R.
    Bernard, P.
    Borradori, L.
    Caproni, M.
    Caux, F.
    Cianchini, G.
    Daneshpazhooh, M.
    De, D.
    Dmochowski, M.
    Drenovska, K.
    Ehrchen, J.
    Feliciani, C.
    Goebeler, M.
    Groves, R.
    Guenther, C.
    Hofmann, S.
    Ioannides, D.
    Kowalewski, C.
    Ludwig, R.
    Lim, Y. L.
    Marinovic, B.
    Marzano, A., V
    Mascaro, J. M. Jr Jr
    Mimouni, D.
    Murrell, D. F.
    Pincelli, C.
    Squarcioni, C. P.
    Sardy, M.
    Setterfield, J.
    Sprecher, E.
    Vassileva, S.
    Wozniak, K.
    Yayli, S.
    Zambruno, G.
    Zillikens, D.
    Hertl, M.
    Schmidt, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (09) : 1900 - 1913
  • [47] Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus
    Tamasi, B.
    Brodszky, V.
    Pentek, M.
    Gulacsi, L.
    Hajdu, K.
    Sardy, M.
    Szegedi, A.
    Bata-Csorgo, Z.
    Kinyo, A.
    Rencz, F.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (04) : 802 - 809
  • [48] Radiation-induced pemphigus vulgaris of the breast
    Vigna-Taglianti, R.
    Russi, E. G.
    Denaro, N.
    Numico, G.
    Brizio, R.
    CANCER RADIOTHERAPIE, 2011, 15 (04): : 334 - 337
  • [49] S2k Guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid
    Eming, Ruediger
    Sticherling, Michael
    Hofmann, Silke C.
    Hunzelmann, Nicolas
    Kern, Johannes S.
    Kramer, Harald
    Pfeiffer, Christiane
    Schuster, Volker
    Zillikens, Detlef
    Goebeler, Matthias
    Hertl, Michael
    Nast, Alexander
    Orzechowski, Hans-Dieter
    Sardy, Miklos
    Schmidt, Enno
    Sitaru, Cassian
    Sporbeck, Birte
    Worm, Margitta
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (08): : 833 - 845
  • [50] Hematological Inflammatory Markers in Patients with Pemphigus Vulgaris
    Lyakhovitsky, Anna
    Dascalu, Joel
    Drousiotis, Theodoulos
    Barzilai, Aviv
    Baum, Sharon
    DERMATOLOGY, 2021, 237 (06) : 912 - 920